We want to discover novel molecular mechanisms involved in human diseases. Understanding these mechanisms might pave the way to novel therapies in cancer and beyond.

To achieve this, we use a wide array of methods in molecular biology, genetics, biochemistry and mass spectrometry. While we are particularly interested in metabolic changes in cancer, we are open to serendipitous discoveries on the way (e.g. the recent discovery of ribitolphosphorylation as a novel posttranslational modification).